Cartography Biosciences
A biotechnology company focused on oncology drug discovery.
About
Cartography Biosciences is a science pipeline platform company developing cancer immunotherapies. They identify and profile antigens at unprecedented scale using single-cell genomics and proteomics to create a comprehensive antigen atlas, enabling the discovery of safer and more effective drug targets. This approach aims to widen the world of treatable cancers by creating precise, broad, and safe therapeutics for patients. Teams look it up for Biotechnology, Oncology, Drug Discovery.
Frequently asked
What does Cartography Biosciences do?
Cartography Biosciences is a Biotechnology company that offers Platform. Teams look it up for Oncology, Drug Discovery, Pharmaceuticals. It is based in South San Francisco, California, USA and was founded in 2021. Public records show $150M in total funding. Compare it on funding, headcount, reviews and nearby alternatives rather than the marketing line alone.
How much funding has Cartography Biosciences raised?
Cartography Biosciences has raised a total of $150M in funding. The most recent round on record is Strategic Investment.
Where is Cartography Biosciences headquartered?
Cartography Biosciences is headquartered in South San Francisco, California, USA.
When was Cartography Biosciences founded?
Cartography Biosciences was founded in 2021.
What industry does Cartography Biosciences operate in?
Cartography Biosciences operates in Biotechnology, Oncology, Drug Discovery, Pharmaceuticals, Biotech.
Strength of the site’s backlink profile, on Ahrefs’ 0-100 Domain Rating scale. Licensed third-party data, not our opinion.
How well an AI agent can read and use this site: structured data, clean markup, and whether key facts are reachable without running JavaScript. We scan the live site.
Google PageSpeed mobile performance for the company’s own site. Measured by Google, not by us.